Informations générales (source: ClinicalTrials.gov)
Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies
Interventional
N/A
Gustave Roussy, Cancer Campus, Grand Paris (Voir sur ClinicalTrials)
juillet 2011
juillet 2020
08 septembre 2025
The aim of the study is to do a descriptive analysis of the cutaneous toxicity observed
in patients treated using targeted therapies in order to have a better understanding of
the skin pathophysiology.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT GUSTAVE ROUSSY | Caroline ROBERT | 31/05/2024 09:27:54 | Contacter | ||
Critères
Tous
Inclusion Criteria:
- Patients with cancer beginning a targeted therapy
- Patients able to follow the protocol
- Age >/= 18 years old
- Signed inform consent
- Patients with cancer beginning a targeted therapy
- Patients able to follow the protocol
- Age >/= 18 years old
- Signed inform consent
- Patient unable to follow the protocol, having a non cooperative behavior or unable
to come to follow up visits or unable to complete the study
- Pregnant or breastfeeding woman